beta-Amyloid (D54D2) Mouse Chimeric Monoclonal Antibody
State & local contract award Virginia Awarded
- Contract number
- A207_PO-0476131
- Awardee
- CELL SIGNALING TECHNOLOGY INC.
- Contracting organization
- University of Virginia
- Cumulative value
- $346.50
About this award
The University of Virginia awarded contract A207_PO-0476131 to Cell Signaling Technology Inc. on September 2, 2026, for the procurement of specialized laboratory reagents. The contract, valued at $346.00, covers the delivery of one beta-Amyloid (D54D2) Mouse Chimeric Monoclonal Antibody unit to recipient Ji Song. This monoclonal antibody product is used in biomedical research applications for detecting and studying amyloid-beta proteins associated with neurodegenerative disease research.
The contract represents a direct purchase of research-grade biological materials by the University of Virginia, a public institution in Virginia. Cell Signaling Technology Inc., the awarded prime contractor, is responsible for supplying the specified antibody product to fulfill the single line item requirement. The relatively modest contract value reflects the transactional nature of this procurement for a discrete laboratory supply component necessary to support the University's research operations.
Line items
| Item | Total |
|---|---|
| beta-Amyloid (D54D2) Mouse Chimeric Monoclonal Antibody | $346.50 |
Award details come from logi.cgieva.com. Updated .
Quick answers
Who was awarded contract A207_PO-0476131?
Contract A207_PO-0476131 was awarded to CELL SIGNALING TECHNOLOGY INC. by University of Virginia on September 2, 2026.
How much is contract A207_PO-0476131 worth?
Its cumulative value is $346.50.
On GovTribe
See this award's full record
- Every line item and file
- The contract it was ordered under and its other orders
- Similar state and local awards and opportunities
- Ask GovTribe AI about this award